Literature DB >> 22168801

Lesioning of TRPV1 expressing primary afferent neurons prevents PAR-2 induced motility, but not mechanical hypersensitivity in the rat colon.

S K Suckow1, E M Anderson, R M Caudle.   

Abstract

BACKGROUND: Proteinase activated receptor 2 (PAR-2) is expressed by many neurons in the colon, including primary afferent neurons that co-express transient receptor potential vanilloid 1 (TRPV1). Activation of PAR-2 receptors was previously found to enhance colonic motility, increase secretion and produce hypersensitivity to mechanical stimuli. This study examined the functional role of TRPV1/PAR-2 expressing neurons that innervate the colon by lesioning TRPV1 bearing neurons with the highly selective and potent TRPV1 agonist resiniferatoxin.
METHODS: Colonic motility in response to PAR-2 activation was evaluated in vitro using isolated segments of descending colon and in vivo using manometry. Colonic mechanical nociceptive thresholds were measured using colorectal distension. Transient receptor potential vanilloid 1 expressing neurons were selectively lesioned with resiniferatoxin. KEY
RESULTS: In vitro, the PAR-2 agonists, trypsin and SLIGRL did not alter contractions of colon segments when applied alone, however, the agents enhanced acetylcholine stimulated contraction. In vivo, PAR-2 agonists administered intraluminally induced contractions of the colon and produced hypersensitivity to colorectal distention. The PAR-2 agonist enhancement of colonic contraction was eliminated when TRPV1 expressing neurons were lesioned with resiniferatoxin, but the PAR-2 agonist induced hypersensitivity remained in the lesioned animals. CONCLUSIONS & INFERENCES: Our findings indicate that TRPV1/PAR-2 expressing primary afferent neurons mediate an extrinsic motor reflex pathway in the colon. These data, coupled with our previous studies, also indicate that the recently described colospinal afferent neurons are nociceptive, suggesting that these neurons may be useful targets for the pharmacological control of pain in diseases such as irritable bowel syndrome.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22168801      PMCID: PMC3276722          DOI: 10.1111/j.1365-2982.2011.01848.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  47 in total

1.  Modulation of capsaicin-evoked visceral pain and referred hyperalgesia by protease-activated receptors 1 and 2.

Authors:  Naoyuki Kawao; Hisao Ikeda; Tomoko Kitano; Ryotaro Kuroda; Fumiko Sekiguchi; Kazuo Kataoka; Yoshihisa Kamanaka; Atsufumi Kawabata
Journal:  J Pharmacol Sci       Date:  2004-03       Impact factor: 3.337

2.  Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats.

Authors:  Anne-Marie Coelho; Nathalie Vergnolle; Bruno Guiard; Jean Fioramonti; Lionel Bueno
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

3.  Role for protease activity in visceral pain in irritable bowel syndrome.

Authors:  Nicolas Cenac; Christopher N Andrews; Marinella Holzhausen; Kevin Chapman; Graeme Cottrell; Patricia Andrade-Gordon; Martin Steinhoff; Giovanni Barbara; Paul Beck; Nigel W Bunnett; Keith A Sharkey; Jose Geraldo P Ferraz; Eldon Shaffer; Nathalie Vergnolle
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

4.  Thermal hypersensitivity in a subset of irritable bowel syndrome patients.

Authors:  Qiqi Zhou; Roger B Fillingim; Joseph L Riley; G Nicholas Verne
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

5.  Uterine inflammation as a noxious visceral stimulus: behavioral characterization in the rat.

Authors:  U Wesselmann; P P Czakanski; G Affaitati; M A Giamberardino
Journal:  Neurosci Lett       Date:  1998-04-24       Impact factor: 3.046

6.  Gut pain and hyperalgesia induced by capsaicin: a human experimental model.

Authors:  Asbjørn Mohr Drewes; Klaus Peter Schipper; Georg Dimcevski; Poul Petersen; Hans Gregersen; Peter Funch-Jensen; Lars Arendt-Nielsen
Journal:  Pain       Date:  2003-07       Impact factor: 6.961

Review 7.  Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging.

Authors:  Donald D Price; Jason G Craggs; QiQi Zhou; G Nicholas Verne; William M Perlstein; Michael E Robinson
Journal:  Neuroimage       Date:  2009-04-16       Impact factor: 6.556

8.  Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control.

Authors:  Laszlo Karai; Dorothy C Brown; Andrew J Mannes; Stephen T Connelly; Jacob Brown; Michael Gandal; Ofer M Wellisch; John K Neubert; Zoltan Olah; Michael J Iadarola
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain.

Authors:  Yi Dai; Tomoko Moriyama; Tomohiro Higashi; Kazuya Togashi; Kimiko Kobayashi; Hiroki Yamanaka; Makoto Tominaga; Koichi Noguchi
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

10.  Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.

Authors:  K Gecse; R Róka; L Ferrier; M Leveque; H Eutamene; C Cartier; A Ait-Belgnaoui; A Rosztóczy; F Izbéki; J Fioramonti; T Wittmann; L Bueno
Journal:  Gut       Date:  2008-01-14       Impact factor: 23.059

View more
  5 in total

1.  Shugan-decoction relieves visceral hyperalgesia and reduces TRPV1 and SP colon expression.

Authors:  Jing-Juan Shang; Jian-Ye Yuan; Hui Xu; Rong-Zhu Tang; Yue-Bin Dong; Jian-Qun Xie
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 2.  Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.

Authors:  Frank Gieseler; Hendrik Ungefroren; Utz Settmacher; Morley D Hollenberg; Roland Kaufmann
Journal:  Cell Commun Signal       Date:  2013-11-11       Impact factor: 5.712

3.  Measurement of Gastrointestinal and Colonic Motor Functions in Humans and Animals.

Authors:  Michael Camilleri; David R Linden
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-07

4.  Therapeutic effect of protease-activated receptor 2 agonist SLIGRL-NH2 on loperamide-induced Sprague-Dawley rat constipation model and the related mechanism.

Authors:  Yonggang Zhang; Tingrui Ge; Ping Xiang; Haibing Mao; Shumin Tang; Aimin Li; Lin Lin; Yinting Wei
Journal:  Drug Des Devel Ther       Date:  2018-08-01       Impact factor: 4.162

Review 5.  Effect of Xiongmatang Extract on Behavioral and TRPV1-CGRP/CGRP-R Pathway in Rats With Migraine.

Authors:  Dingding Liu; Lulu Chang; Jingru Wang; Qiang Zhu; Ning Jiang; Mudassar Azhar; Ayaz Ahmed; Guirong Zeng
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.